BeBetter Med (SHSE:688759) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688759 BeBetter Med Inc SHSE:688759
4 GF Score
Price ¥23.20
View Full Analysis

What is BeBetter Med Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:688759 vs VRTX, REGN, RVMD: Short Interest Comparison

For the Biotechnology subindustry, BeBetter Med's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BeBetter Med Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeBetter Med's Short Interest distribution charts can be found below:

* The bar in red indicates where BeBetter Med's Short Interest falls into.


SHSE:688759
4GF Score
BeBetter Med Inc SHSE:688759
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BeBetter Med Business Description

Address No. 25 Yayingshi Road, Room 802, 8th Floor, Building A-3, Science City, High-tech Industrial Development Zone, Guangzhou, Guangdong, CHN, 510663
BeBetter Med Inc is a biopharmaceutical company based in China, focusing on independent research and development of drugs. The company focuses on developing novel medicines for treating cancers, autoimmune diseases, and other severe conditions. Key products include the PI3K/HDAC dual inhibitor BEBT-908 and multiple drugs in clinical trial phases targeting cancers. It's a United States subsidiary BeBetter Pharma specializes in next-generation siRNA therapeutics using proprietary delivery platforms aimed at complex diseases like kidney disorders, metabolic and liver diseases, and neurodegenerative conditions. Its pipeline includes oral and injectable drug candidates, some in late-stage trials, and aims to address unmet medical needs through novel mechanisms.
4GF Score

Get the complete analysis for SHSE:688759

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.20
Price